Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii. (Q37139121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

2

Jones RN

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

3

Erwin ME

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Biedenbach DJ

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Microbiology

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

2828-2830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic

28 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Cefixime disk susceptibility test criteria

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

BMY 28100, a new oral cephalosporin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266029

Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines

14 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8253998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro antibacterial activity of FK482, a new orally active cephalosporin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8253998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8253998%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

PubMed publication ID

8253998

1 reference